Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study

Abstract

IntroductionAngina with no obstructive coronary artery disease (ANOCA) is a common syndrome with unmet clinical needs. Microvascular and vasospastic angina are relevant but may not be diagnosed without measuring coronary vascular function. The relationship between cardiovascular magnetic resonance (CMR)-derived myocardial blood flow (MBF) and reference invasive coronary function tests is uncertain. We hypothesise that multiparametric CMR assessment will be clinically useful in the ANOCA diagnostic pathway.Methods/analysisThe Stratified Medical Therapy Using Invasive Coronary Function Testing In Angina (CorMicA) trial is a prospective, blinded, randomised, sham-controlled study comparing two management approaches in patients with ANOCA. We aim to recruit consecutive patients with stable angina undergoing elective invasive coronary angiography. Eligible patients with ANOCA (n=150) will be randomised to invasive coronary artery function-guided diagnosis and treatment (intervention group) or not (control group). Based on these test results, patients will be stratified into disease endotypes: microvascular angina, vasospastic angina, mixed microvascular/vasospastic angina, obstructive epicardial coronary artery disease and non-cardiac chest pain. After randomisation in CorMicA, subjects will be invited to participate in the Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) substudy. Patients will undergo multiparametric CMR and have assessments of MBF (using a novel pixel-wise fully quantitative method), left ventricular function and mass, and tissue characterisation (T1 mapping and late gadolinium enhancement imaging). Abnormalities of myocardial perfusion and associations between MBF and invasive coronary artery function tests will be assessed. The CorCMR substudy represents the largest cohort of ANOCA patients with paired multiparametric CMR and comprehensive invasive coronary vascular function tests.Ethics/disseminationThe CorMicA trial and CorCMR substudy have UK REC approval (ref.16/WS/0192).Trial registration number NCT03193294.

Angina: contemporary diagnosis and management

“…Non-invasive functional testing includes myocardial perfusion scintigraphy, exercise treadmill testing (including stress echocardiography) or contrast-enhanced stress perfusion MRI depending on local availability. Novel pixel-wise absolute perfusion quantification of myocardial perfusion by CMR will likely improve the efficiency of absolute quantification of myocardial blood flow by CMR 38. PET is the reference-standard non-invasive assessment of myocardial blood flow permitting quantitative flow derivation in mL/g/min.…”

Microvascular Disease and Small-Vessel Disease: The Nexus of Multiple Diseases of Women

“…80 The MRI substudy of the CorMicA trial in patients with angina, but without obstructive CAD will be the largest study to assess the association of quantitative myocardial perfusion by MRI with invasive coronary vascular function testing. 81…”

Coronary Artery Spasm: New Insights

“…Recent studies suggest, however, that a reduced myocardial blood flow or asynchronism in myocardial perfusion outlined by CMRI indicates CAS. e advantage of performing CMRI in MINOCA patients is eliminating other potential differential diagnoses such as takotsubo and myocarditis and then favoring a CAS attack [120,121].…”